Should Older Men with Age-Related Decline in Testosterone levels Receive Testosterone Replacement?
Thursday, May 7, 2020
9:15 AM – 10:00 AM
Participants should be aware of the following financial/non-financial relationships: Shalender Bhasin: AbbVie : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Alivegen : Research Grant (Status: Ongoing); MIB : Research Grant (Status: Ongoing); OPKO : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Transition Therapeutics : Research Grant (Status: Ongoing) Elizabeth N. Pearce, MD, MSc, FACE: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Evaluate the health consequences of age-related decline in testosterone levels.
Recognize the potential benefits and risks of testosterone replacement in older men with age-related decline.
Synthesize the data from the randomized clinical trials of testosterone to guide shared decision to treat or not to treat older men with testosterone replacement therapy.